Celltrion Recovers With High-Margin US Sales

Company Files For Donepezil Patch With Korean Ministry of Food and Drug Safety

 
• By Akriti Seth
  
Business strategy
Celltrion delivered a strong quarter as it revealed plans to continue launching biosimilars in new markets • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products